Of 1,950 adults with obesity who started a GLP-1 medication, 753 had enough wearable-device data to be analyzed
The perceived load level is measured based on the subject's perception of exertion, including increased heart rate, breathing or respiratory rate, sweating, and muscle fatigue
The follow up period used to examine outcomes irrespective of ongoing use of the medication (emulating a modified intention-to-treat analysis of a clinical trial), started from the index date, and continued until study end (October 30, 2021), death, or initiation of a GLP1-RA in the DPP4i group, whichever came first (Fig
Veelgestelde Vragen over Melanotan 2 (FAQ) Hieronder vindt u antwoorden op enkele van de meest gestelde vragen door onderzoekers die Melanotan 2 kopen of gebruiken in hun lab